NCT04326257 2026-01-08Personalized Immunotherapy in Patients With Recurrent /Metastatic SCCHN That Have Progressed on Prior ImmunotherapyUniversity of PittsburghPhase 2 Completed20 enrolled 13 charts
NCT06101134 2025-04-14A Study to Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose CombinationsBristol-Myers SquibbPhase 2 Active not recruiting100 enrolled